Global Melphalan Injection Market Growth 2020-2025

  • receipt Report ID : 59748
  • calendar_today Published On: May, 2020
  • file_copy Pages: 131
  • list Pharmaceuticals and Healthcare
Buy @ $3660

COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.

According to this latest study, the 2020 growth of Melphalan Injection will have significant change from previous year. By the most conservative estimates of global Melphalan Injection market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Melphalan Injection market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Melphalan Injection market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Melphalan Injection, covering the supply chain analysis, impact assessment to the Melphalan Injection market size growth rate in several scenarios, and the measures to be undertaken by Melphalan Injection companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

50mg/vial

10mg/vial

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

Hospital

Clinics

Recovery Center

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Fresenius Kabi

Mediclone Biotech

Dr. Reddy's

Meitheal Pharmaceutical

GSK

Athenex

Spectrum Pharmaceuticals

Mylan

Par Pharmaceuticals

Sagent

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Melphalan Injection consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

To understand the structure of Melphalan Injection market by identifying its various subsegments.

Focuses on the key global Melphalan Injection manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Melphalan Injection with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Melphalan Injection submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Data Source

1.6 Economic Indicators

1.7 Currency Considered

1.8 What is the Impact of Covid-19 Outbreak On the Melphalan Injection?

1.8.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.

1.8.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.

1.8.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Melphalan Injection Market Size in 2020, by Scenario

1.8.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Melphalan Injection Consumption 2015-2025

2.1.2 Melphalan Injection Consumption CAGR by Region

2.2 Melphalan Injection Segment by Type

2.2.1 50mg/vial

2.2.2 10mg/vial

2.3 Melphalan Injection Consumption by Type

2.3.1 Global Melphalan Injection Consumption Market Share by Type (2015-2020)

2.3.2 Global Melphalan Injection Revenue and Market Share by Type (2015-2020)

2.3.3 Global Melphalan Injection Sale Price by Type (2015-2020)

2.4 Melphalan Injection Segment by Application

2.4.1 Hospital

2.4.2 Clinics

2.4.3 Recovery Center

2.5 Melphalan Injection Consumption by Application

2.5.1 Global Melphalan Injection Consumption Market Share by Type (2015-2020)

2.5.2 Global Melphalan Injection Value and Market Share by Type (2015-2020)

2.5.3 Global Melphalan Injection Sale Price by Type (2015-2020)

3 Global Melphalan Injection by Company

3.1 Global Melphalan Injection Sales Market Share by Company

3.1.1 Global Melphalan Injection Sales by Company (2018-2020)

3.1.2 Global Melphalan Injection Sales Market Share by Company (2018-2020)

3.2 Global Melphalan Injection Revenue Market Share by Company

3.2.1 Global Melphalan Injection Revenue by Company (2018-2020)

3.2.2 Global Melphalan Injection Revenue Market Share by Company (2018-2020)

3.3 Global Melphalan Injection Sale Price by Company

3.4 Global Melphalan Injection Manufacturing Base Distribution, Sales Area, Type by Company

3.4.1 Global Melphalan Injection Manufacturing Base Distribution and Sales Area by Company

3.4.2 Players Melphalan Injection Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Melphalan Injection by Regions

4.1 Melphalan Injection by Regions

4.2 Americas Melphalan Injection Consumption Growth

4.3 APAC Melphalan Injection Consumption Growth

4.4 Europe Melphalan Injection Consumption Growth

4.5 Middle East & Africa Melphalan Injection Consumption Growth

5 Americas

5.1 Americas Melphalan Injection Consumption by Countries

5.1.1 Americas Melphalan Injection Consumption by Countries (2015-2020)

5.1.2 Americas Melphalan Injection Value by Countries (2015-2020)

5.2 Americas Melphalan Injection Consumption by Type

5.3 Americas Melphalan Injection Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

5.8 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Melphalan Injection Consumption by Regions

6.1.1 APAC Melphalan Injection Consumption by Regions (2015-2020)

6.1.2 APAC Melphalan Injection Value by Regions (2015-2020)

6.2 APAC Melphalan Injection Consumption by Type

6.3 APAC Melphalan Injection Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Regions

7 Europe

7.1 Europe Melphalan Injection by Countries

7.1.1 Europe Melphalan Injection Consumption by Countries (2015-2020)

7.1.2 Europe Melphalan Injection Value by Countries (2015-2020)

7.2 Europe Melphalan Injection Consumption by Type

7.3 Europe Melphalan Injection Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Melphalan Injection by Countries

8.1.1 Middle East & Africa Melphalan Injection Consumption by Countries (2015-2020)

8.1.2 Middle East & Africa Melphalan Injection Value by Countries (2015-2020)

8.2 Middle East & Africa Melphalan Injection Consumption by Type

8.3 Middle East & Africa Melphalan Injection Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Melphalan Injection Distributors

10.3 Melphalan Injection Customer

11 Global Melphalan Injection Market Forecast

11.1 Global Melphalan Injection Consumption Forecast (2021-2025)

11.2 Global Melphalan Injection Forecast by Regions

11.2.1 Global Melphalan Injection Forecast by Regions (2021-2025)

11.2.2 Global Melphalan Injection Value Forecast by Regions (2021-2025)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Melphalan Injection Forecast by Type

11.8 Global Melphalan Injection Forecast by Application

12 Key Players Analysis

12.1 Fresenius Kabi

12.1.1 Company Information

12.1.2 Melphalan Injection Product Offered

12.1.3 Fresenius Kabi Melphalan Injection Sales, Revenue, Price and Gross Margin (2018-2020)

12.1.4 Main Business Overview

12.1.5 Fresenius Kabi Latest Developments

12.2 Mediclone Biotech

12.2.1 Company Information

12.2.2 Melphalan Injection Product Offered

12.2.3 Mediclone Biotech Melphalan Injection Sales, Revenue, Price and Gross Margin (2018-2020)

12.2.4 Main Business Overview

12.2.5 Mediclone Biotech Latest Developments

12.3 Dr. Reddy's

12.3.1 Company Information

12.3.2 Melphalan Injection Product Offered

12.3.3 Dr. Reddy's Melphalan Injection Sales, Revenue, Price and Gross Margin (2018-2020)

12.3.4 Main Business Overview

12.3.5 Dr. Reddy's Latest Developments

12.4 Meitheal Pharmaceutical

12.4.1 Company Information

12.4.2 Melphalan Injection Product Offered

12.4.3 Meitheal Pharmaceutical Melphalan Injection Sales, Revenue, Price and Gross Margin (2018-2020)

12.4.4 Main Business Overview

12.4.5 Meitheal Pharmaceutical Latest Developments

12.5 GSK

12.5.1 Company Information

12.5.2 Melphalan Injection Product Offered

12.5.3 GSK Melphalan Injection Sales, Revenue, Price and Gross Margin (2018-2020)

12.5.4 Main Business Overview

12.5.5 GSK Latest Developments

12.6 Athenex

12.6.1 Company Information

12.6.2 Melphalan Injection Product Offered

12.6.3 Athenex Melphalan Injection Sales, Revenue, Price and Gross Margin (2018-2020)

12.6.4 Main Business Overview

12.6.5 Athenex Latest Developments

12.7 Spectrum Pharmaceuticals

12.7.1 Company Information

12.7.2 Melphalan Injection Product Offered

12.7.3 Spectrum Pharmaceuticals Melphalan Injection Sales, Revenue, Price and Gross Margin (2018-2020)

12.7.4 Main Business Overview

12.7.5 Spectrum Pharmaceuticals Latest Developments

12.8 Mylan

12.8.1 Company Information

12.8.2 Melphalan Injection Product Offered

12.8.3 Mylan Melphalan Injection Sales, Revenue, Price and Gross Margin (2018-2020)

12.8.4 Main Business Overview

12.8.5 Mylan Latest Developments

12.9 Par Pharmaceuticals

12.9.1 Company Information

12.9.2 Melphalan Injection Product Offered

12.9.3 Par Pharmaceuticals Melphalan Injection Sales, Revenue, Price and Gross Margin (2018-2020)

12.9.4 Main Business Overview

12.9.5 Par Pharmaceuticals Latest Developments

12.10 Sagent

12.10.1 Company Information

12.10.2 Melphalan Injection Product Offered

12.10.3 Sagent Melphalan Injection Sales, Revenue, Price and Gross Margin (2018-2020)

12.10.4 Main Business Overview

12.10.5 Sagent Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Melphalan Injection Market Size in 2020, by Scenario

Table 2. COVID-19: Measures to be Undertaken by Melphalan Injection Companies

Table 3. Research Methodology

Table 4. Data Source

Table 5. Melphalan Injection Consumption CAGR by Region 2015-2025 ($ Millions)

Table 6. Major Players of 50mg/vial

Table 7. Major Players of 10mg/vial

Table 8. Global Consumption Sales by Type (2015-2020)

Table 9. Global Melphalan Injection Consumption Market Share by Type (2015-2020)

Table 10. Global Melphalan Injection Revenue by Type (2015-2020) ($ million)

Table 11. Global Melphalan Injection Value Market Share by Type (2015-2020) ($ Millions)

Table 12. Global Melphalan Injection Sale Price by Type (2015-2020)

Table 13. Global Consumption Sales by Application (2015-2020)

Table 14. Global Melphalan Injection Consumption Market Share by Application (2015-2020)

Table 15. Global Melphalan Injection Value by Application (2015-2020)

Table 16. Global Melphalan Injection Value Market Share by Application (2015-2020)

Table 17. Global Melphalan Injection Sale Price by Application (2015-2020)

Table 18. Global Melphalan Injection Sales by Company (2017-2019) (K Units)

Table 19. Global Melphalan Injection Sales Market Share by Company (2017-2019)

Table 20. Global Melphalan Injection Revenue by Company (2017-2019) ($ Millions)

Table 21. Global Melphalan Injection Revenue Market Share by Company (2017-2019)

Table 22. Global Melphalan Injection Sale Price by Company (2017-2019)

Table 23. Global Melphalan Injection Manufacturing Base Distribution and Sales Area by Manufacturers

Table 24. Players Melphalan Injection Products Offered

Table 25. Melphalan Injection Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

Table 26. Global Melphalan Injection Consumption by Regions 2015-2020 (K Units)

Table 27. Global Melphalan Injection Consumption Market Share by Regions 2015-2020

Table 28. Global Melphalan Injection Value by Regions 2015-2020 ($ Millions)

Table 29. Global Melphalan Injection Value Market Share by Regions 2015-2020

Table 30. Americas Melphalan Injection Consumption by Countries (2015-2020) (K Units)

Table 31. Americas Melphalan Injection Consumption Market Share by Countries (2015-2020)

Table 32. Americas Melphalan Injection Value by Countries (2015-2020) ($ Millions)

Table 33. Americas Melphalan Injection Value Market Share by Countries (2015-2020)

Table 34. Americas Melphalan Injection Consumption by Type (2015-2020) (K Units)

Table 35. Americas Melphalan Injection Consumption Market Share by Type (2015-2020)

Table 36. Americas Melphalan Injection Consumption by Application (2015-2020) (K Units)

Table 37. Americas Melphalan Injection Consumption Market Share by Application (2015-2020)

Table 38. APAC Melphalan Injection Consumption by Countries (2015-2020) (K Units)

Table 39. APAC Melphalan Injection Consumption Market Share by Countries (2015-2020)

Table 40. APAC Melphalan Injection Value by Regions (2015-2020) ($ Millions)

Table 41. APAC Melphalan Injection Value Market Share by Regions (2015-2020)

Table 42. APAC Melphalan Injection Consumption by Type (2015-2020) (K Units)

Table 43. APAC Melphalan Injection Consumption Market Share by Type (2015-2020)

Table 44. APAC Melphalan Injection Consumption by Application (2015-2020) (K Units)

Table 45. APAC Melphalan Injection Consumption Market Share by Application (2015-2020)

Table 46. Europe Melphalan Injection Consumption by Countries (2015-2020) (K Units)

Table 47. Europe Melphalan Injection Consumption Market Share by Countries (2015-2020)

Table 48. Europe Melphalan Injection Value by Countries (2015-2020) ($ Millions)

Table 49. Europe Melphalan Injection Value Market Share by Countries (2015-2020)

Table 50. Europe Melphalan Injection Consumption by Type (2015-2020) (K Units)

Table 51. Europe Melphalan Injection Consumption Market Share by Type (2015-2020)

Table 52. Europe Melphalan Injection Consumption by Application (2015-2020) (K Units)

Table 53. Europe Melphalan Injection Consumption Market Share by Application (2015-2020)

Table 54. Middle East & Africa Melphalan Injection Consumption by Countries (2015-2020) (K Units)

Table 55. Middle East & Africa Melphalan Injection Consumption Market Share by Countries (2015-2020)

Table 56. Middle East & Africa Melphalan Injection Value by Countries (2015-2020) ($ Millions)

Table 57. Middle East & Africa Melphalan Injection Value Market Share by Countries (2015-2020)

Table 58. Middle East & Africa Melphalan Injection Consumption by Type (2015-2020) (K Units)

Table 59. Middle East & Africa Melphalan Injection Consumption Market Share by Type (2015-2020)

Table 60. Middle East & Africa Melphalan Injection Consumption by Application (2015-2020) (K Units)

Table 61. Middle East & Africa Melphalan Injection Consumption Market Share by Application (2015-2020)

Table 62. Melphalan Injection Distributors List

Table 63. Melphalan Injection Customer List

Table 64. Global Melphalan Injection Consumption Forecast by Countries (2021-2025) (K Units)

Table 65. Global Melphalan Injection Consumption Market Forecast by Regions

Table 66. Global Melphalan Injection Value Forecast by Countries (2021-2025) ($ Millions)

Table 67. Global Melphalan Injection Value Market Share Forecast by Regions

Table 68. Global Melphalan Injection Consumption Forecast by Type (2021-2025) (K Units)

Table 69. Global Melphalan Injection Consumption Market Share Forecast by Type (2021-2025)

Table 70. Global Melphalan Injection Value Forecast by Type (2021-2025) ($ Millions)

Table 71. Global Melphalan Injection Value Market Share Forecast by Type (2021-2025)

Table 72. Global Melphalan Injection Consumption Forecast by Application (2021-2025) (K Units)

Table 73. Global Melphalan Injection Consumption Market Share Forecast by Application (2021-2025)

Table 74. Global Melphalan Injection Value Forecast by Application (2021-2025) ($ Millions)

Table 75. Global Melphalan Injection Value Market Share Forecast by Application (2021-2025)

Table 76. Fresenius Kabi Product Offered

Table 77. Fresenius Kabi Melphalan Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 78. Fresenius Kabi Main Business

Table 79. Fresenius Kabi Latest Developments

Table 80. Fresenius Kabi Basic Information, Company Total Revenue (in $ million), Melphalan Injection Manufacturing Base, Sales Area and Its Competitors

Table 81. Mediclone Biotech Product Offered

Table 82. Mediclone Biotech Melphalan Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 83. Mediclone Biotech Main Business

Table 84. Mediclone Biotech Latest Developments

Table 85. Mediclone Biotech Basic Information, Company Total Revenue (in $ million), Melphalan Injection Manufacturing Base, Sales Area and Its Competitors

Table 86. Dr. Reddy's Product Offered

Table 87. Dr. Reddy's Melphalan Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 88. Dr. Reddy's Main Business

Table 89. Dr. Reddy's Latest Developments

Table 90. Dr. Reddy's Basic Information, Company Total Revenue (in $ million), Melphalan Injection Manufacturing Base, Sales Area and Its Competitors

Table 91. Meitheal Pharmaceutical Product Offered

Table 92. Meitheal Pharmaceutical Melphalan Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 93. Meitheal Pharmaceutical Main Business

Table 94. Meitheal Pharmaceutical Latest Developments

Table 95. Meitheal Pharmaceutical Basic Information, Company Total Revenue (in $ million), Melphalan Injection Manufacturing Base, Sales Area and Its Competitors

Table 96. GSK Product Offered

Table 97. GSK Melphalan Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 98. GSK Main Business

Table 99. GSK Latest Developments

Table 100. GSK Basic Information, Company Total Revenue (in $ million), Melphalan Injection Manufacturing Base, Sales Area and Its Competitors

Table 101. Athenex Product Offered

Table 102. Athenex Melphalan Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 103. Athenex Main Business

Table 104. Athenex Latest Developments

Table 105. Athenex Basic Information, Company Total Revenue (in $ million), Melphalan Injection Manufacturing Base, Sales Area and Its Competitors

Table 106. Spectrum Pharmaceuticals Product Offered

Table 107. Spectrum Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Melphalan Injection Manufacturing Base, Sales Area and Its Competitors

Table 108. Spectrum Pharmaceuticals Main Business

Table 109. Spectrum Pharmaceuticals Latest Developments

Table 110. Spectrum Pharmaceuticals Melphalan Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 111. Mylan Product Offered

Table 112. Mylan Melphalan Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 113. Mylan Main Business

Table 114. Mylan Latest Developments

Table 115. Mylan Basic Information, Company Total Revenue (in $ million), Melphalan Injection Manufacturing Base, Sales Area and Its Competitors

Table 116. Par Pharmaceuticals Product Offered

Table 117. Par Pharmaceuticals Melphalan Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 118. Par Pharmaceuticals Main Business

Table 119. Par Pharmaceuticals Latest Developments

Table 120. Par Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Melphalan Injection Manufacturing Base, Sales Area and Its Competitors

Table 121. Sagent Product Offered

Table 122. Sagent Melphalan Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 123. Sagent Main Business

Table 124. Sagent Latest Developments

Table 125. Sagent Basic Information, Company Total Revenue (in $ million), Melphalan Injection Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Melphalan Injection

Figure 2. Melphalan Injection Report Years Considered

Figure 3. Market Research Methodology

Figure 4. Global Melphalan Injection Consumption Growth Rate 2015-2025 (K Units)

Figure 5. Global Melphalan Injection Value Growth Rate 2015-2025 ($ Millions)

Figure 6. Product Picture of 50mg/vial

Figure 7. Product Picture of 10mg/vial

Figure 8. Global Melphalan Injection Consumption Market Share by Type (2015-2020)

Figure 9. Global Melphalan Injection Value Market Share by Type (2015-2020)

Figure 10. Melphalan Injection Consumed in Hospital

Figure 11. Global Melphalan Injection Market: Hospital (2015-2020) (K Units)

Figure 12. Global Melphalan Injection Market: Hospital (2015-2020) ($ Millions)

Figure 13. Melphalan Injection Consumed in Clinics

Figure 14. Global Melphalan Injection Market: Clinics (2015-2020) (K Units)

Figure 15. Global Melphalan Injection Market: Clinics (2015-2020) ($ Millions)

Figure 16. Melphalan Injection Consumed in Recovery Center

Figure 17. Global Melphalan Injection Market: Recovery Center (2015-2020) (K Units)

Figure 18. Global Melphalan Injection Market: Recovery Center (2015-2020) ($ Millions)

Figure 19. Global Melphalan Injection Consumption Market Share by Application (2015-2020)

Figure 20. Global Melphalan Injection Value Market Share by Application (2015-2020)

Figure 21. Global Melphalan Injection Sales Market Share by Company in 2017

Figure 22. Global Melphalan Injection Sales Market Share by Company in 2019

Figure 23. Global Melphalan Injection Revenue Market Share by Company in 2017

Figure 24. Global Melphalan Injection Revenue Market Share by Company in 2019

Figure 25. Global Melphalan Injection Sale Price by Company in 2019

Figure 26. Global Melphalan Injection Consumption Market Share by Regions 2015-2020

Figure 27. Global Melphalan Injection Value Market Share by Regions 2015-2020

Figure 28. Americas Melphalan Injection Consumption 2015-2020 (K Units)

Figure 29. Americas Melphalan Injection Value 2015-2020 ($ Millions)

Figure 30. APAC Melphalan Injection Consumption 2015-2020 (K Units)

Figure 31. APAC Melphalan Injection Value 2015-2020 ($ Millions)

Figure 32. Europe Melphalan Injection Consumption 2015-2020 (K Units)

Figure 33. Europe Melphalan Injection Value 2015-2020 ($ Millions)

Figure 34. Middle East & Africa Melphalan Injection Consumption 2015-2020 (K Units)

Figure 35. Middle East & Africa Melphalan Injection Value 2015-2020 ($ Millions)

Figure 36. Americas Melphalan Injection Consumption Market Share by Countries in 2019

Figure 37. Americas Melphalan Injection Value Market Share by Countries in 2019

Figure 38. Americas Melphalan Injection Consumption Market Share by Type in 2019

Figure 39. Americas Melphalan Injection Consumption Market Share by Application in 2019

Figure 40. United States Melphalan Injection Consumption Growth 2015-2020 (K Units)

Figure 41. United States Melphalan Injection Value Growth 2015-2020 ($ Millions)

Figure 42. Canada Melphalan Injection Consumption Growth 2015-2020 (K Units)

Figure 43. Canada Melphalan Injection Value Growth 2015-2020 ($ Millions)

Figure 44. Mexico Melphalan Injection Consumption Growth 2015-2020 (K Units)

Figure 45. Mexico Melphalan Injection Value Growth 2015-2020 ($ Millions)

Figure 46. APAC Melphalan Injection Consumption Market Share by Countries in 2019

Figure 47. APAC Melphalan Injection Value Market Share by Regions in 2019

Figure 48. APAC Melphalan Injection Consumption Market Share by Type in 2019

Figure 49. APAC Melphalan Injection Consumption Market Share by Application in 2019

Figure 50. China Melphalan Injection Consumption Growth 2015-2020 (K Units)

Figure 51. China Melphalan Injection Value Growth 2015-2020 ($ Millions)

Figure 52. Japan Melphalan Injection Consumption Growth 2015-2020 (K Units)

Figure 53. Japan Melphalan Injection Value Growth 2015-2020 ($ Millions)

Figure 54. Korea Melphalan Injection Consumption Growth 2015-2020 (K Units)

Figure 55. Korea Melphalan Injection Value Growth 2015-2020 ($ Millions)

Figure 56. Southeast Asia Melphalan Injection Consumption Growth 2015-2020 (K Units)

Figure 57. Southeast Asia Melphalan Injection Value Growth 2015-2020 ($ Millions)

Figure 58. India Melphalan Injection Consumption Growth 2015-2020 (K Units)

Figure 59. India Melphalan Injection Value Growth 2015-2020 ($ Millions)

Figure 60. Australia Melphalan Injection Consumption Growth 2015-2020 (K Units)

Figure 61. Australia Melphalan Injection Value Growth 2015-2020 ($ Millions)

Figure 62. Europe Melphalan Injection Consumption Market Share by Countries in 2019

Figure 63. Europe Melphalan Injection Value Market Share by Countries in 2019

Figure 64. Europe Melphalan Injection Consumption Market Share by Type in 2019

Figure 65. Europe Melphalan Injection Consumption Market Share by Application in 2019

Figure 66. Germany Melphalan Injection Consumption Growth 2015-2020 (K Units)

Figure 67. Germany Melphalan Injection Value Growth 2015-2020 ($ Millions)

Figure 68. France Melphalan Injection Consumption Growth 2015-2020 (K Units)

Figure 69. France Melphalan Injection Value Growth 2015-2020 ($ Millions)

Figure 70. UK Melphalan Injection Consumption Growth 2015-2020 (K Units)

Figure 71. UK Melphalan Injection Value Growth 2015-2020 ($ Millions)

Figure 72. Italy Melphalan Injection Consumption Growth 2015-2020 (K Units)

Figure 73. Italy Melphalan Injection Value Growth 2015-2020 ($ Millions)

Figure 74. Russia Melphalan Injection Consumption Growth 2015-2020 (K Units)

Figure 75. Russia Melphalan Injection Value Growth 2015-2020 ($ Millions)

Figure 76. Middle East & Africa Melphalan Injection Consumption Market Share by Countries in 2019

Figure 77. Middle East & Africa Melphalan Injection Value Market Share by Countries in 2019

Figure 78. Middle East & Africa Melphalan Injection Consumption Market Share by Type in 2019

Figure 79. Middle East & Africa Melphalan Injection Consumption Market Share by Application in 2019

Figure 80. Egypt Melphalan Injection Consumption Growth 2015-2020 (K Units)

Figure 81. Egypt Melphalan Injection Value Growth 2015-2020 ($ Millions)

Figure 82. South Africa Melphalan Injection Consumption Growth 2015-2020 (K Units)

Figure 83. South Africa Melphalan Injection Value Growth 2015-2020 ($ Millions)

Figure 84. Israel Melphalan Injection Consumption Growth 2015-2020 (K Units)

Figure 85. Israel Melphalan Injection Value Growth 2015-2020 ($ Millions)

Figure 86. Turkey Melphalan Injection Consumption Growth 2015-2020 (K Units)

Figure 87. Turkey Melphalan Injection Value Growth 2015-2020 ($ Millions)

Figure 88. GCC Countries Melphalan Injection Consumption Growth 2015-2020 (K Units)

Figure 89. GCC Countries Melphalan Injection Value Growth 2015-2020 ($ Millions)

Figure 90. Global Melphalan Injection Consumption Growth Rate Forecast (2021-2025) (K Units)

Figure 91. Global Melphalan Injection Value Growth Rate Forecast (2021-2025) ($ Millions)

Figure 92. Americas Melphalan Injection Consumption 2021-2025 (K Units)

Figure 93. Americas Melphalan Injection Value 2021-2025 ($ Millions)

Figure 94. APAC Melphalan Injection Consumption 2021-2025 (K Units)

Figure 95. APAC Melphalan Injection Value 2021-2025 ($ Millions)

Figure 96. Europe Melphalan Injection Consumption 2021-2025 (K Units)

Figure 97. Europe Melphalan Injection Value 2021-2025 ($ Millions)

Figure 98. Middle East & Africa Melphalan Injection Consumption 2021-2025 (K Units)

Figure 99. Middle East & Africa Melphalan Injection Value 2021-2025 ($ Millions)

Figure 100. United States Melphalan Injection Consumption 2021-2025 (K Units)

Figure 101. United States Melphalan Injection Value 2021-2025 ($ Millions)

Figure 102. Canada Melphalan Injection Consumption 2021-2025 (K Units)

Figure 103. Canada Melphalan Injection Value 2021-2025 ($ Millions)

Figure 104. Mexico Melphalan Injection Consumption 2021-2025 (K Units)

Figure 105. Mexico Melphalan Injection Value 2021-2025 ($ Millions)

Figure 106. Brazil Melphalan Injection Consumption 2021-2025 (K Units)

Figure 107. Brazil Melphalan Injection Value 2021-2025 ($ Millions)

Figure 108. China Melphalan Injection Consumption 2021-2025 (K Units)

Figure 109. China Melphalan Injection Value 2021-2025 ($ Millions)

Figure 110. Japan Melphalan Injection Consumption 2021-2025 (K Units)

Figure 111. Japan Melphalan Injection Value 2021-2025 ($ Millions)

Figure 112. Korea Melphalan Injection Consumption 2021-2025 (K Units)

Figure 113. Korea Melphalan Injection Value 2021-2025 ($ Millions)

Figure 114. Southeast Asia Melphalan Injection Consumption 2021-2025 (K Units)

Figure 115. Southeast Asia Melphalan Injection Value 2021-2025 ($ Millions)

Figure 116. India Melphalan Injection Consumption 2021-2025 (K Units)

Figure 117. India Melphalan Injection Value 2021-2025 ($ Millions)

Figure 118. Australia Melphalan Injection Consumption 2021-2025 (K Units)

Figure 119. Australia Melphalan Injection Value 2021-2025 ($ Millions)

Figure 120. Germany Melphalan Injection Consumption 2021-2025 (K Units)

Figure 121. Germany Melphalan Injection Value 2021-2025 ($ Millions)

Figure 122. France Melphalan Injection Consumption 2021-2025 (K Units)

Figure 123. France Melphalan Injection Value 2021-2025 ($ Millions)

Figure 124. UK Melphalan Injection Consumption 2021-2025 (K Units)

Figure 125. UK Melphalan Injection Value 2021-2025 ($ Millions)

Figure 126. Italy Melphalan Injection Consumption 2021-2025 (K Units)

Figure 127. Italy Melphalan Injection Value 2021-2025 ($ Millions)

Figure 128. Russia Melphalan Injection Consumption 2021-2025 (K Units)

Figure 129. Russia Melphalan Injection Value 2021-2025 ($ Millions)

Figure 130. Spain Melphalan Injection Consumption 2021-2025 (K Units)

Figure 131. Spain Melphalan Injection Value 2021-2025 ($ Millions)

Figure 132. Egypt Melphalan Injection Consumption 2021-2025 (K Units)

Figure 133. Egypt Melphalan Injection Value 2021-2025 ($ Millions)

Figure 134. South Africa Melphalan Injection Consumption 2021-2025 (K Units)

Figure 135. South Africa Melphalan Injection Value 2021-2025 ($ Millions)

Figure 136. Israel Melphalan Injection Consumption 2021-2025 (K Units)

Figure 137. Israel Melphalan Injection Value 2021-2025 ($ Millions)

Figure 138. Turkey Melphalan Injection Consumption 2021-2025 (K Units)

Figure 139. Turkey Melphalan Injection Value 2021-2025 ($ Millions)

Figure 140. GCC Countries Melphalan Injection Consumption 2021-2025 (K Units)

Figure 141. GCC Countries Melphalan Injection Value 2021-2025 ($ Millions)

Figure 142. Fresenius Kabi Melphalan Injection Market Share (2018-2020)

Figure 143. Mediclone Biotech Melphalan Injection Market Share (2018-2020)

Figure 144. Dr. Reddy's Melphalan Injection Market Share (2018-2020)

Figure 145. Meitheal Pharmaceutical Melphalan Injection Market Share (2018-2020)

Figure 146. GSK Melphalan Injection Market Share (2018-2020)

Figure 147. Athenex Melphalan Injection Market Share (2018-2020)

Figure 148. Spectrum Pharmaceuticals Melphalan Injection Market Share (2018-2020)

Figure 149. Mylan Melphalan Injection Market Share (2018-2020)

Figure 150. Par Pharmaceuticals Melphalan Injection Market Share (2018-2020)

Figure 151. Sagent Melphalan Injection Market Share (2018-2020)